Published in Clin Infect Dis on August 01, 2010
Ventilator-associated pneumonia in the ICU. Crit Care (2014) 1.82
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis (2011) 1.22
Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis (2010) 1.16
A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother (2012) 1.02
Temporal trends of ventilator-associated pneumonia incidence and the effect of implementing health-care bundles in a suburban community. Chest (2013) 0.88
Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia. Sci Rep (2015) 0.82
Ventilator-associated pneumonia in patients admitted to intensive care units, using open or closed endotracheal suctioning. Anesth Pain Med (2014) 0.81
More about chest physiotherapy and ventilator-associated pneumonia prevention. Indian J Crit Care Med (2010) 0.80
Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial. Ann Intensive Care (2016) 0.76
A translational approach to ventilator associated pneumonia. Clin Transl Med (2014) 0.75
Authors' reply. Indian J Crit Care Med (2010) 0.75
Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study. Ann Intensive Care (2016) 0.75
Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections. PLoS One (2017) 0.75
Impact of chlorhexidine mouthwash prophylaxis on probable ventilator-associated pneumonia in a surgical intensive care unit. Int J Crit Illn Inj Sci (2016) 0.75
High-throughput sequencing of 16S rDNA amplicons characterizes bacterial composition in bronchoalveolar lavage fluid in patients with ventilator-associated pneumonia. Drug Des Devel Ther (2015) 0.75
Microbial profiling of dental plaque from mechanically ventilated patients. J Med Microbiol (2015) 0.75
Intubated Trauma Patients Receiving Prolonged Antibiotics for Pneumonia despite Negative Cultures: Predictors and Outcomes. Surg Infect (Larchmt) (2016) 0.75
Can enteral antibiotics be used to treat pneumonia in the surgical intensive care unit? A clinical outcomes and cost comparison. Int J Crit Illn Inj Sci (2015) 0.75
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med (2006) 4.85
Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med (2004) 3.97
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88
Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med (2012) 3.86
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20
Blood transfusion and nosocomial infection: another brick in the wall. Crit Care Med (2006) 3.00
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest (2006) 2.73
Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients. Crit Care Med (2012) 2.65
Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery. Crit Care Med (2008) 2.43
Ethical assessment of industry-sponsored clinical trials: a case analysis. Chest (2002) 2.27
Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion (2010) 2.24
Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest (2005) 2.20
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12
Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: a retrospective analysis. J Crit Care (2012) 2.09
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest (2009) 2.09
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83
Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest (2010) 1.81
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61
Accuracy of previous estimates for adult prolonged acute mechanical ventilation volume in 2020: update using 2000-2008 data. Crit Care Med (2012) 1.57
Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States. Crit Care Med (2008) 1.50
Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis. Respiration (2004) 1.48
Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest (2008) 1.47
Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest (2009) 1.47
Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Infect Control Hosp Epidemiol (2013) 1.45
Unnecessary use of placebo controls: the case of asthma clinical trials. Arch Intern Med (2002) 1.44
Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration (2004) 1.44
The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study. Chest (2015) 1.43
Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol (2008) 1.42
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis (2010) 1.29
Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med (2006) 1.25
FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials. Clin Infect Dis (2014) 1.25
Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin (2008) 1.23
Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning. BMC Health Serv Res (2008) 1.23
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis (2011) 1.22
Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med (2002) 1.20
Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J (2008) 1.20
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care (2007) 1.14
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis (2008) 1.10
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis. Crit Care (2011) 1.09
Antimicrobial stewardship: shepherding precious resources. Am J Health Syst Pharm (2009) 1.08
An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma (2009) 1.08
Mitigating VTE in soldiers from Operation Iraqi Freedom and Operation Enduring Freedom. Chest (2014) 1.07
Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med (2008) 1.05
Development and validation of a mortality risk-adjustment model for patients hospitalized for exacerbations of chronic obstructive pulmonary disease. Med Care (2013) 1.03
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis (2013) 1.03
Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med (2009) 1.01
Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med (2009) 1.01
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med (2010) 1.00
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections. BMC Infect Dis (2012) 1.00
Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. J Hosp Med (2010) 0.99
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care (2013) 0.99
Venous thromboembolic disease in the intensive care unit. Semin Respir Crit Care Med (2010) 0.98
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. Clin Infect Dis (2008) 0.97
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation. Crit Care (2009) 0.97
Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. J Crit Care (2010) 0.96
The protein C pathway: implications for the design of the RESPOND study. Crit Care (2007) 0.96
Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors. Infect Control Hosp Epidemiol (2009) 0.96
The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome. J Crit Care (2011) 0.96
Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study. Crit Care (2008) 0.95
Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med (2009) 0.95
The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. J Crit Care (2008) 0.93
Fungal infections in the ICU. Infect Dis Clin North Am (2009) 0.92
Health care-associated pneumonia: identification and initial management in the ED. Am J Emerg Med (2008) 0.92
Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest (2008) 0.91
Economics at the end of life: hospital and ICU perspectives. Semin Respir Crit Care Med (2012) 0.91
Economic aspects of preventing health care-associated infections in the intensive care unit. Crit Care Clin (2012) 0.91
Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc (2006) 0.88
Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. Chest (2007) 0.87
Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia. J Hosp Med (2010) 0.87
Prolonged acute mechanical ventilation: implications for hospital benchmarking. Chest (2008) 0.86
Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC Infect Dis (2014) 0.86
Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease. Respir Med (2005) 0.85
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Clin Infect Dis (2003) 0.85
Healthcare-associated pneumonia: the state of evidence to date. Curr Opin Pulm Med (2011) 0.85
Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU. Curr Opin Infect Dis (2011) 0.84
Application of a population-based severity scoring system to individual patients results in frequent misclassification. Crit Care (2005) 0.84
Health care-associated candidemia--a distinct entity? J Hosp Med (2010) 0.84
Update in ventilator-associated pneumonia. Curr Opin Anaesthesiol (2006) 0.84
Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis (2014) 0.83
Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival. Antimicrob Agents Chemother (2014) 0.83
Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trials. Chest (2007) 0.83
Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. BMC Health Serv Res (2007) 0.82
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect Dis (2011) 0.82
Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies. Am J Health Syst Pharm (2009) 0.82
Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation. BMJ Open (2012) 0.82
Epidemiology of healthcare-associated pneumonia (HCAP). Semin Respir Crit Care Med (2009) 0.81
Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. Chest (2002) 0.81
Preventing clostridium difficile infection in the intensive care unit. Crit Care Clin (2013) 0.81
Do intensive care unit patients have intensive care unit physicians? Unfortunately not. Crit Care Med (2006) 0.80
Antibiotics in the critically ill: the bug, drug, host triad. Chest (2012) 0.79
Effect of standardized orders and provider education on head-of-bed positioning in mechanically ventilated patients. Crit Care Med (2003) 0.79
A 36-year-old Haitian man with coma, acute kidney injury, lactic acidosis, and respiratory failure. Chest (2012) 0.79
Intralobular bronchopulmonary sequestrations associated with bronchogenic cysts. Respir Med (2005) 0.78
No longer the "expensive scare unit"? Crit Care Med (2004) 0.78
Economic and outcomes aspects of venous thromboembolic disease. Crit Care Clin (2011) 0.78
AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. IRB (1993) 0.78